← Glossary

Supplemental New Drug Application

sNDA

FDA & Regulatory

A supplemental New Drug Application (sNDA) seeks FDA approval to change an already-approved drug — most often to add a new indication, dosage, or label expansion. Approvals can unlock additional addressable markets for a marketed product.

Related terms

New Drug ApplicationBiologics License Application

Track Supplemental New Drug Application across 1,000+ biotechs

BioSniper monitors FDA decisions, clinical trials, and catalysts in real time — with evidence-backed AI analysis.

Start Free